Trial Profile
The Role of the P2Y12 Receptor in Tissue Factor Induced Coagulation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary)
- Indications Thrombosis
- Focus Pharmacodynamics
- 13 Dec 2011 Results presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology.
- 08 Jul 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 08 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.